Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen
- 28 February 1989
- journal article
- Published by Elsevier BV in Journal of Pediatric Surgery
- Vol. 24 (2), 189-193
- https://doi.org/10.1016/s0022-3468(89)80247-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicatorJournal of Pediatric Surgery, 1987
- High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.Journal of Clinical Oncology, 1987
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- MASS SCREENING FOR NEUROBLASTOMA IN INFANTS IN JAPANThe Lancet, 1984
- Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.Journal of Clinical Oncology, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Nude mouse xenograft study for treatment of neuroblastoma: Effects of chemotherapeutic agents and surgery on tumor growth and cell kineticsJournal of Pediatric Surgery, 1984
- Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazolecarboxamideAmerican Journal of Clinical Oncology, 1984
- Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study groupMedical and Pediatric Oncology, 1979